NANCY TREJO: Open Payments
NPI 1811162563 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 7 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $345 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Amgen Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
| Biogen, Inc. | 1 | $13 |
Products named: Kerendia, KEVEYIS, MOUNJARO, OTEZLA, REXULTI, MAVYRET, SKYCLARYS.
Industry payments across NY — which companies pay providers there.
